Header image

Company Presentations

Tuesday, October 21, 2025
12:30 PM - 1:25 PM

Details

Chair: Rosanne Hyland, Deputy Chief Executive Officer, AusBiotech Arovella Therapeutics - Michael Baker, Chief Executive Officer & Managing Director ISOBiotech - Elizabeth Edrich, Chief Executive Officer Neuroscientific Biopharmaceuticals - Nathan Smith, Chief Executive Officer QBiotics Group Ltd - Ebru Davidson, General Counsel Invion - Thian Chew, Executive Chair & Chief Executive Officer Q&A

loading